Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Expert Review of Hematology|June 21, 2021
Improving symptom burden and quality of life in patients with myelofibrosis: current strategies and future directionsJames Yoon, Kristen PettitCurrent Hematologic Malignancy Reports|November 4, 2017
Novel Therapies for MyelofibrosisKristen Pettit, Olatoyosi OdenikeFrontiers in Oncology|December 24, 2015
Defining and Treating Older Adults with Acute Myeloid Leukemia Who Are Ineligible for Intensive TherapiesKristen Pettit, Olatoyosi OdenikeCurrent Hematologic Malignancy Reports|August 23, 2020
Non-Pharmacologic Management of Splenomegaly for Patients with Myelofibrosis: Is There Any Role for Splenectomy or Splenic Radiation in 2020?Kamya Sankar, Kristen PettitExpert Review of Hematology|July 8, 2016
Blast-phase myeloproliferative neoplasms: risk factors and treatment approachesKristen Pettit, Olatoyosi OdenikeHematology. American Society of Hematology. Education Program|December 9, 2022
New approaches to tackle cytopenic myelofibrosisSamuel B Reynolds, Kristen PettitClinical Lymphoma, Myeloma & Leukemia|April 17, 2019
SOHO State of the Art Updates and Next Questions: MyelofibrosisKristen Pettit, Srdan Verstovsek, Moshe TalpazLeukemia & Lymphoma|June 9, 2016
Incorporating measurable ('minimal') residual disease-directed treatment strategies to optimize outcomes in adults with acute myeloid leukemiaKristen Pettit, Wendy Stock, Roland B WalterAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 6, 2022
Management of Myeloproliferative Neoplasms in the Molecular Era: From Research to PracticeKristen Pettit, Alexandra Rezazadeh, Ehab L Atallah, et al.Cancers|September 28, 2023
Exploring the Molecular Landscape of Myelofibrosis, with a Focus on Ras and Mitogen-Activated Protein (MAP) Kinase SignalingSamuel B Reynolds, Kristen Pettit, Malathi Kandarpa, et al.Pageof 4